Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefazolin sodium, quantity: 1048 mg (equivalent: cefazolin, qty 1000 mg) - injection, powder for - excipient ingredients: - cephazolin sodium injection is indicated in the treatment of the following serious infections due to susceptible organisms: 1. respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephazolin sodium is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin sodium in the subsequent prevention of rheumatic fever are not available at present 2. gentinourinary tract infections due to esch. coli, pr. mirabilis, klebsiella species and some strains of enterobacter and enterococci. 3. skin and soft-tissue infections due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci and other strains of streptococci. 4. bone and joint infections due to staph. aureus. 5. septicaemia due to s. pneumoniae, staph. aureus (penicillin-sensitive and penicillin- resistant), pr. mirabilia, esch. coli and klebsiella species. 6. endocarditis due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cephazolin sodium.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefazolin sodium, quantity: 524 mg (equivalent: cefazolin, qty 500 mg) - injection, powder for - excipient ingredients: - cephazolin sodium injection is indicated in the treatment of the following serious infections due to susceptible organisms: 1. respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephazolin sodium is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin sodium in the subsequent prevention of rheumatic fever are not available. 2. gentinourinary tract infections due to esch. coli, pr. mirabilis, klebsiella species and some strains of enterobacter and enterococci. 3. skin and soft-tissue infections due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci and other strains of streptococci. 4. bone and joint infections due to staph. aureus. 5. septicaemia due to s. pneumoniae, staph. aureus (penicillin-sensitive and penicillin- resistant), pr. mirabilia, esch. coli and klebsiella species. 6. endocarditis due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cephazolin sodium.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - suxamethonium chloride dihydrate, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; hydrochloric acid - for the production of skeletal muscle relaxation in anaesthesia. suited for procedures requiring only brief relaxation such as endotracheal intubation, endoscopic examinations, orthopaedic manipulations, short surgical procedures and electro-convulsive therapy.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - metronidazole, quantity: 500 mg - injection, solution - excipient ingredients: water for injections; citric acid; sodium chloride; dibasic sodium phosphate - metronidazole juno is indicated for:treatment of severe anaerobic infection when oral medication is not possible or is contraindicated, when immediate anti-anaerobic therapy is required. metronidazole may be used prophylactically to prevent infection of the surgical site which may have been contaminated or potentially contaminated with anaerobic organisms. procedures in which this may be assumed to have happened include appendectomy, colonic surgery, vaginal hysterectomy, abdominal surgery in the presence of anaerobes in the peritoneal cavity and surgery performed in the presence of anaerobic septicaemia.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cisatracurium besilate, quantity: 211.05 mg (equivalent: cisatracurium, qty 157.5 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cisatracurium besilate, quantity: 14.07 mg (equivalent: cisatracurium, qty 10.5 mg) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cisatracurium besilate, quantity: 28.14 mg (equivalent: cisatracurium, qty 21 mg) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cisatracurium besilate, quantity: 7.04 mg - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 4 mg (equivalent: noradrenaline (norepinephrine), qty 2 mg) - injection, concentrated - excipient ingredients: water for injections; sodium chloride - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). ,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - noradrenaline (norepinephrine) acid tartrate monohydrate, quantity: 8 mg (equivalent: noradrenaline (norepinephrine), qty 4 mg) - injection, concentrated - excipient ingredients: sodium chloride; water for injections - for the restoration of blood pressure in certain acute hypotensive states (e.g. phaeochromocytomectomy, sympathectomy, poliomyelitis, spinal anaesthesia, myocardial infarction, septicaemia, blood transfusion and drug reactions). ,as an adjunct in the treatment of cardiac arrest. to restore and maintain an adequate blood pressure after an effective heartbeat and ventilation have been established by other means.